Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

18.26
+0.52002.93%
Volume:1.35M
Turnover:24.60M
Market Cap:37.54B
PE:9.60
High:18.38
Open:17.68
Low:17.68
Close:17.74
52wk High:18.38
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:1.01
T/O Rate:0.57%
Dividend:0.99
Dividend Rate:5.43%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.83
PE(LYR):15.68

Loading ...

AUDI E7X Debuts with Ambilight EC Smart Dimming Panoramic Roof

prnewswire
·
May 12

Ecopetrol President Ricardo Roa Charged by Colombia's Prosecutor's Office With Breaches of Campaign Spending Limits

MT Newswires Live
·
May 12

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

GlobeNewswire
·
May 12

HENLIUS Gains EU Approval for Two New Indications of Serplulimab Injection

Stock News
·
May 10

EC World REIT Probed Over Unauthorized Guarantee After RMB3.5 Billion Court Ruling

TIPRANKS
·
May 09

Ecopetrol SA expected to post earnings of 47 cents a share - Earnings Preview

Reuters
·
May 09

EC World REIT faces final court ruling on Fuyang Futoufa guarantees

TIPRANKS
·
May 08

Press Release: Pharming Group reports first quarter 2026 financial results; on track for Joenja(R) U.S. pediatric label expansion and launches in Japan and Europe in 2026

Dow Jones
·
May 07

Moody’s downgrades Ecopetrol’s global credit rating to Ba2

TIPRANKS
·
May 07

Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference

GlobeNewswire
·
May 06

Royalty Pharma reports first quarter 2026 results

GlobeNewswire
·
May 06

UBS Sticks to Its Hold Rating for Ecopetrol SA (EC)

TIPRANKS
·
May 06

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 06

Ecopetrol Is Maintained at Neutral by UBS

Dow Jones
·
May 06

Ecopetrol price target raised to $13.50 from $10 at UBS

TIPRANKS
·
May 05

UBS Adjusts Price Target on Ecopetrol to $13.50 From $10, Maintains Neutral Rating

MT Newswires Live
·
May 05

Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

GlobeNewswire
·
May 05

Earning Preview: Ecopetrol SA Q1 revenue is expected to decrease by 3.14%, and institutional views are cautious

Earnings Agent
·
May 05

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

GlobeNewswire
·
May 04

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
May 01